Hubei Bio-pharmaceutical Industrial Technological Institute Inc.
Clinical trials sponsored by Hubei Bio-pharmaceutical Industrial Technological Institute Inc., explained in plain language.
-
New ointment aims to clear precancerous skin spots
Disease control Not yet recruitingThis study tests an ointment called HW211026 on adults with actinic keratosis, a common precancerous skin condition caused by sun damage. The goal is to see if the ointment can completely clear the lesions on the face. Eighty participants will use the ointment and be monitored fo…
Phase: PHASE2 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Disease control
Last updated May 17, 2026 04:36 UTC
-
New hope for chronic cough sufferers: experimental drug aims to quiet the hacking
Symptom relief Not yet recruitingThis study tests an experimental drug called HW091077 in 180 adults with a chronic cough that has lasted at least a year and hasn't responded to other treatments. The goal is to see if the drug can reduce how often people cough and how severe it feels. Participants will be random…
Phase: PHASE2 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
New IPF drug candidate tested in healthy people for first time
Knowledge-focused Not yet recruitingThis early-stage study tests the safety of a new tablet called HW252001 in 98 healthy adults aged 18 to 55. Participants receive either the drug or a placebo, and researchers monitor side effects and how the drug moves through the body. The goal is to gather safety information, n…
Phase: PHASE1 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC